About microMend
microMend is a company based in Seattle (United States) founded in 2017. microMend has raised $3.41 million across 3 funding rounds. microMend offers products and services including microMend 2-in-1 Wound Repair Kit, microMend Laceration Kit with Large Devices, microMend Laceration Kit with Medium Devices, microMend Multi Pack with Medium Devices, and microMend Variety Pack. microMend operates in a competitive market with competitors including Kerecis, Kitotech Medical, PolyNovo, Contraline and Aroa Biosurgery, among others.
- Headquarter Seattle, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kitotech Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.41 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of microMend
microMend offers a comprehensive portfolio of products and services, including microMend 2-in-1 Wound Repair Kit, microMend Laceration Kit with Large Devices, microMend Laceration Kit with Medium Devices, microMend Multi Pack with Medium Devices, and microMend Variety Pack.
Kit for fast, painless wound closure without sutures.
Device for closing larger wounds quickly and effectively.
Tool for medium wound closure with minimal scarring.
Multi-device pack for various wound sizes and applications.
Assortment of devices for diverse wound closure needs.
Funding Insights of microMend
microMend has successfully raised a total of $3.41M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by microMend
Investment portfolio details for microMend
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - microMend
Detailed financials for microMend
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Micromend Comparisons
Peer comparison for microMend
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of microMend
microMend operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Kitotech Medical, PolyNovo, Contraline and Aroa Biosurgery, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| Locked | Locked | Locked |
Developer of a device to close wounds, lacerations, and surgical incisions
|
|
| Locked | Locked | Locked |
Developer of biodegradable temporising matrix for treating traumatic wounds
|
|
| Locked | Locked | Locked |
Contraline is focused on developing innovative male contraception solutions.
|
|
| Locked | Locked | Locked |
Developer of medical and surgical products for soft tissue reconstruction
|
Detailed competitors of microMend
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Micromend
Complete news archive for microMend
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about microMend
microMend was founded in 2017 and raised its 1st funding round 3 years after it was founded.
microMend is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
microMend is a funded company, having raised a total of $3.41M across 3 funding rounds to date.
MicroMend was founded in 2017 and is based in Seattle, United States. Operations focus on the medical device sector, specifically solutions for dermatological treatments. A wound closure device is developed that applies tiny staples to the skin edges of wounds, functioning similarly to a butterfly bandage. This approach is designed to be painless and to facilitate wound healing up to three times faster than with sutures.
microMend's top competitors include Kerecis, Kitotech Medical and PolyNovo.
microMend offers microMend 2-in-1 Wound Repair Kit, microMend Laceration Kit with Large Devices, microMend Laceration Kit with Medium Devices, microMend Multi Pack with Medium Devices, and microMend Variety Pack.